- Report
- January 2026
- 180 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- April 2025
- 136 Pages
Global
From €3511EUR$3,999USD£3,037GBP
- Report
- January 2026
- 276 Pages
Global
From €2195EUR$2,500USD£1,899GBP
- Report
- November 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- September 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- August 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 80 Pages
United States
From €5223EUR$5,950USD£4,519GBP
- Report
- September 2024
- 100 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- April 2023
- 100 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- March 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,152GBP
- Report
- September 2025
- 88 Pages
India
From €3073EUR$3,500USD£2,658GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3073EUR$3,500USD£2,658GBP
- Report
- October 2024
- 87 Pages
India
From €3073EUR$3,500USD£2,658GBP
- Report
- August 2022
- 120 Pages
Global
From €4170EUR$4,750USD£3,608GBP
- Report
- April 2023
- 111 Pages
Global
From €4170EUR$4,750USD£3,608GBP
- Report
- July 2023
- 140 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- January 2025
- 145 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2023
- 185 Pages
Global
€4209EUR$4,795USD£3,642GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more